Has BCG attenuated to impotence? [6]

Nature

Volumn 389, Issue 6647, 1997, Pages 133-134

  Behr, Marcel A ^a   Small, Peter M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

BCG VACCINATION; DRUG EFFICACY; HUMAN; IMMUNOGENICITY; INFECTION CONTROL; LETTER; PRIORITY JOURNAL; STRAIN DIFFERENCE; TUBERCULOSIS;

MYCOBACTERIUM BOVIS BCG;

EID: 0030874748     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/38151     Document Type: Letter

References (10)

1. Comstock, G. W. Control Clin. Trials 15, 247-276 (1994).
2. Calmette, A. Proc. R. Soc. Med. 24, 85-94 (1931).
3. Edwards, L. B. & Gelting, A. S. Bull. World Health Org. 3, 279-300 (1950).
4. Orme, I. M. & Collins, F. M. Cell. Immunol. 84, 113-120 (1984).
5. Dubos, R. J. & Pierce, C. H. Am. Rev. Tuberculosis 74, 699-717 (1948).
6. Jespersen, A. & Bentzon, M. W. Acta Tuberculosis Pneumol. Scand. 44, 253-289 (1964).
7. Dubos, R. & Dubos, J. The White Plague: Tuberculosis, Man and Society 163 (Little, Brown & Co., Boston, 1952).
8. Frappier, A. & Panisset, M. La Souche du BCG 93 (Institut de Microbiol. et d'Hygiene, Univ. Montreal, Montreal, Canada, 1957).
9. Colditz, G. A. et al J. Am. Med. Assoc. 271, 698-702 (1994).
10. Aronson, J. D. Am. Rev. Tuberculosis 58, 255-281 (1948).